Globus Medical Inc
NYSE:GMED
Globus Medical Inc
NYSE:GMED
Price:
64.72 USD
0.56%
Market Closed
Updated:
May 12, 2024
Globus Medical Inc
Income from Continuing Operations
|
Globus Medical Inc
Income from Continuing Operations Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Globus Medical Inc
NYSE:GMED
|
Income from Continuing Operations
$66.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
0%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Globus Medical Inc's Income from Continuing Operations?
Income from Continuing Operations
66.6m
USD
66.6m
USD
Based on the financial report for Mar 31, 2024, Globus Medical Inc's Income from Continuing Operations amounts to 66.6m USD.
What is Globus Medical Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
0%
0%
Over the last year, the Income from Continuing Operations growth was -67%. The average annual Income from Continuing Operations growth rates for Globus Medical Inc have been -18% over the past three years , -15% over the past five years .
You don't have any saved screeners yet
